Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource.

Autor: Morris J; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Kunkel MW; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., White SL; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Wishka DG; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Lopez OD; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Bowles L; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Sellers Brady P; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Ramsey P; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Grams J; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Rohrer T; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Martin K; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Dexheimer TS; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Coussens NP; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Evans D; Target Validation and Screening Laboratory, Applied and Developmental Research Directorate, Frederick National, Laboratory for Cancer Research, Frederick, Maryland., Risbood P; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Sonkin D; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Williams JD; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Polley EC; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Collins JM; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland., Teicher BA; Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Nov 01; Vol. 22 (11), pp. 1270-1279.